StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
4189.T$2771.00-0.25%
Fair $2771.00+0.0%

4189.T

KH Neochem Co., Ltd.

Basic Materials / ChemicalsTokyo

$2771.00

-7.00 (-0.25%)

Fairly Valued+0.0%Fair Value $2771.00Fund rank 28/100 · Data gapFallback financials|
SA 49/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $7.9B · quality 49.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · 4189.TLocal privado en este navegador · KH Neochem Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$97.0B

P/E

12.7x

↓

EV/EBITDA

6.4x

↓

ROE

11.2%

↑

Gross Margin

21.6%

↑

Debt/Equity

0.26

↑
52-Week Range$2771
$2315$3125

TradingView lightweight chart

4189.T price, volumen y niveles de valoración

Último $2,771Periodo +121.7%
Fair value: $2,771

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.1%

FCF CAGR

—

FCF margin

7.8%

FCF / Net income

1.15x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $115.10B · net income $7.80B · FCF $8.98B

2022-FY → 2025-FY

Gross margin

21.6%+0.3% pts

Operating margin

9.8%-1.1% pts

Net margin

6.8%-0.3% pts

FCF margin

7.8%+12.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$115.10B$115.10B$119.76B$115.22B$114.88B
Net Income$7.80B$7.80B$8.36B$6.83B$8.07B
EBITDA$17.32B$17.32B$16.99B$14.46B$16.01B
EPS218.15218.15225.81184.23217.73
Gross Margin21.6%21.6%21.1%19.0%21.3%
Operating Margin9.8%9.8%10.2%8.6%10.8%
Net Margin6.8%6.8%7.0%5.9%7.0%
Balance Sheet
Debt/Equity0.260.260.280.260.38
Current Ratio1.601.60———
Cash Flow
Free Cash Flow$8.98B$8.98B$-1.64B$7.94B$-5.36B
Returns
ROE11.2%11.2%12.1%10.7%13.6%
Valuation
P/E12.7112.719.0212.5312.13
EV/EBITDA6.396.395.156.386.84
P/B1.421.421.091.341.65
Growth & Yield
Revenue Growth-3.9%-3.9%3.9%0.3%—
EPS Growth-3.4%-3.4%22.6%-15.4%—
Dividend Yield4.0%4.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

4.1%

fácil

EPS terminal req.

$245.88

Spread vs growth

-7.5%

5Y implied EPS CAGR

6.4%

razonable

EPS terminal req.

$297.51

Spread vs growth

-9.8%

10Y implied EPS CAGR

8.2%

razonable

EPS terminal req.

$479.15

Spread vs growth

-11.6%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +22.1%

Total return

+22.1%

Start / end P/E

10.4x → 12.7x

EPS bridge

225.81 → 218.15

Residual

-0.8%

EPS growth-3.4%
Multiple rerating+22.3%
Dividend+4.0%
Residual / FX / buybacks / cross-term-0.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.